KOREA ARLICO PHARM CO.,LTD. Logo

KOREA ARLICO PHARM CO.,LTD.

Develops, manufactures, and sells generic and other pharmaceutical products.

260660 | KO

Overview

Corporate Details

ISIN(s):
KR7260660006
LEI:
Country:
South Korea
Address:
서울특별시 서초구 바우뫼로27길 7-21 (양재동), 서초구

Description

Korea Arlico Pharm Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes prescription (ETC) and over-the-counter (OTC) drugs, medical devices, and oriental medical preparations, with a specialization in generic pharmaceuticals. Operating from a KGMP-certified facility, it focuses on continuous innovation to improve human health. The company serves its domestic market and exports its products to numerous countries, with the goal of expanding its global presence.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 761.7 KB
2025-06-18 00:00
주식등의대량보유상황보고서(일반)
Korean 116.0 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 679.2 KB
2025-04-30 00:00
소속부변경
Korean 3.6 KB
2025-03-28 00:00
정기주주총회결과
Korean 21.8 KB
2025-03-20 00:00
감사보고서제출
Korean 17.8 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 1.1 MB
2025-03-06 00:00
의결권대리행사권유참고서류
Korean 83.6 KB
2025-02-26 00:00
주주총회집중일개최사유신고
Korean 5.7 KB
2025-02-26 00:00
주주총회소집공고
Korean 81.1 KB
2025-02-25 00:00
주주총회소집결의
Korean 11.0 KB
2025-02-12 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.3 KB
2025-02-12 00:00
현금ㆍ현물배당결정
Korean 9.1 KB
2024-12-17 00:00
주식등의대량보유상황보고서(일반)
Korean 127.6 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB

Automate Your Workflow. Get a real-time feed of all KOREA ARLICO PHARM CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOREA ARLICO PHARM CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOREA ARLICO PHARM CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.